<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SII-42036</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Siegfried Project</narrative>
  </title>
  <description type="2">
   <narrative xml:lang="EN">- Increased exports:  the Pharmaceutical sector was officially declared as a strategic export sector for the Government of Mexico (&quot;GoM&quot;).  Siegfried&apos;s growth strategy to expand outside of Mexico is in line with the GoM priorities as it aims at increasing exports and strengthening Mexico&apos;s regional competitiveness.

- South-South knowledge transfer:  As Siegfried expands its regional footprint, it will bring new products, more stringent operational and quality practices, as well as knowledge and technology transfer to other countries.

- Increased supply of generics: The Project has the potential to increase competitiveness in the pharmaceutical market through the entry and expansion of a generic pharmaceutical manufacturer that will introduce a greater variety of medicine and sell medicine at relatively lower prices than the originator brands.  The entry of additional generics companies into markets leads to further price reductions as competitive pressures intensify.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">Founded 45 years ago, Siegfried Rhein, S.A. de C.V. (Siegfried or the Company) is a Mexico-based, pharmaceutical company focused on the development, manufacture and sales of generic medicines.&#xA0; Siegfried owns two manufacturing facilities located in Queretaro, Mexico.&#xA0; It is one of the leading domestic pharmaceutical company in Mexico, primarily focused on prescription generics, with a portfolio of 89 products covering the following therapeutic areas: analgesics, antibiotics, cardiovascular, gastrointestinal, womens health, central nervous system, and pediatrics.&#xA0; The Company has one of the largest pharmaceutical sales forces in Mexico and employs more than 1,200 people.  The proposed IFCs financing aims to support Siegfrieds expansion plan which includes the acquisition of additional brands, regional expansion in Central America and other expenditures associated with Siegfrieds expansion plan (the Project).</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">SIEGFRIED RHEIN, S.A. DE C.V.</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SII-42036" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-06" type="1"></activity-date>
  <activity-date iso-date="2019-01-10" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">0  0  0  0  0  0  0  0  0.0000         Pablo Damian Urue&#xF1;a    Director de   Administraci&#xF3;n   y   Finanzas    Antonio Doval&#xED; Jaime #70,   Torre D, Piso12,   Colonia   Santa Fe Del. &#xC1;lvaro Obreg&#xF3;n   C.P. 01210   M&#xE9;xico, Ciudad de M&#xE9;xico  .    Email:    pablo.uruena@siegfried.com.mx     www.siegfried.com.mx</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Siegfried Rhein, S.A. de C.V.  Pablo Damian Urue&#xF1;a  Director de Administraci&#xF3;n y Finanzas  (52+55)1055-2600  pablo.uruena@siegfried.com.mx  Antonio Doval&#xED; Jaime #70, D12, Colonia Santa Fe Del. &#xC1;lvaro Obreg&#xF3;n C.P. 01210 Mexico, Mexico City  www.siegfried.com.mx</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="MX" percentage="100">
   <narrative xml:lang="EN">Mexico</narrative>
  </recipient-country>
  <location ref="MX-Mexico">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">The expenditures to be funded through the Project will be for expansion in Mexico and Central America.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>23.0000000000 -102.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">other</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $75.00 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="411"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2019-01-06"></period-start>
   <period-end iso-date="2019-06-30"></period-end>
   <value currency="USD" value-date="2019-01-06">75000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-06"></transaction-date>
   <value currency="USD" value-date="2019-01-06">75000000</value>
   <receiver-org>
    <narrative xml:lang="EN">SIEGFRIED RHEIN, S.A. DE C.V.</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="411"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SII/42036/siegfried-project">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information - Anticipated Impact Measurement &amp; Monitoring (AIMM) Assessment and Main Environmental &amp; Social Risks and Impacts of the Project</narrative>
   </title>
   <category code="A01"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SII/42036/siegfried-project">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
